Literature DB >> 12645085

L-phenylalanine selectively depresses currents at glutamatergic excitatory synapses.

A V Glushakov1, D M Dennis, C Sumners, C N Seubert, A E Martynyuk.   

Abstract

To explore the hypothesis that L-phenylalanine (L-Phe) depresses glutamatergic synaptic transmission and thus contributes to brain dysfunction in phenylketonuria (PKU), the effects of L-Phe on spontaneous and miniature excitatory postsynaptic currents (s/mEPSCs) in rat and mouse hippocampal and cerebrocortical cultured neurons were studied using the patch-clamp technique. L-Phe depressed the amplitude and frequency of both N-methyl-D-aspartate (NMDA) and non-NMDA components of glutamate receptor (GluR) s/mEPSCs. The IC(50) of L-Phe to inhibit non-NMDAR mEPSC frequency was 0.98 +/- 0.13 mM, a brain concentration seen in classical PKU. In contrast, D-Phe had a significantly smaller effect, whereas L-leucine, an amino acid that competes with L-Phe for brain transporter, had no effect on mEPSCs. Unlike GluR s/mEPSCs, GABA receptor mIPSCs were not attenuated by L-Phe. A high extracellular concentration of glycine prevented the attenuation by L-Phe of NMDAR current, activated by exogenous agonist, and of NMDAR s/mEPSC amplitude, but not of NMDAR s/mEPSC frequency. On the other hand, L-Phe significantly depressed non-NMDAR current activated by low but not high concentrations of exogenous agonists. Glycine-independent attenuation of NMDAR s/mEPSC frequency suggests decreased presynaptic glutamate release caused by L-Phe, whereas decreased amplitudes of NMDAR and non-NMDAR s/mEPSCs are consistent with competition of L-Phe for the glycine- and glutamate-binding sites of NMDARs and non-NMDARs, respectively. The finding that GluR activity is significantly depressed at conditions characteristic of classical PKU indicates a potentially important contribution of impaired GluR function to PKU-related mental retardation and provides important insights into the potential physiological consequences of impaired GluR function. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12645085     DOI: 10.1002/jnr.10569

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  15 in total

Review 1.  Diffusion-weighted imaging of acute excitotoxic brain injury.

Authors:  Toshio Moritani; Wendy R K Smoker; Yutaka Sato; Yuji Numaguchi; Per-Lennart A Westesson
Journal:  AJNR Am J Neuroradiol       Date:  2005-02       Impact factor: 3.825

2.  Effects of phenylalanine and its metabolites on cytoplasmic free calcium in cortical neurons.

Authors:  Y G Yu; F G Tang; J Pan; X F Gu
Journal:  Neurochem Res       Date:  2007-03-31       Impact factor: 3.996

3.  Experimental evidence that phenylalanine provokes oxidative stress in hippocampus and cerebral cortex of developing rats.

Authors:  Carolina G Fernandes; Guilhian Leipnitz; Bianca Seminotti; Alexandre U Amaral; Angela Zanatta; Carmen R Vargas; Carlos S Dutra Filho; Moacir Wajner
Journal:  Cell Mol Neurobiol       Date:  2009-09-23       Impact factor: 5.046

4.  Biochemical, Metabolic, and Behavioral Characteristics of Immature Chronic Hyperphenylalanemic Rats.

Authors:  Gerald A Dienel; Nancy F Cruz
Journal:  Neurochem Res       Date:  2015-07-30       Impact factor: 3.996

Review 5.  Pathogenesis of CNS involvement in disorders of amino and organic acid metabolism.

Authors:  S Kölker; S W Sauer; G F Hoffmann; I Müller; M A Morath; J G Okun
Journal:  J Inherit Metab Dis       Date:  2008-04-04       Impact factor: 4.982

Review 6.  Metabolism of amino acid neurotransmitters: the synaptic disorder underlying inherited metabolic diseases.

Authors:  Stefan Kölker
Journal:  J Inherit Metab Dis       Date:  2018-06-04       Impact factor: 4.982

7.  Effects of phenylalanine on the survival and neurite outgrowth of rat cortical neurons in primary cultures: possible involvement of brain-derived neurotrophic factor.

Authors:  Duan Li; Xuefan Gu; Lihua Lu; Lili Liang
Journal:  Mol Cell Biochem       Date:  2010-01-27       Impact factor: 3.396

8.  Gender dimorphism in aspartame-induced impairment of spatial cognition and insulin sensitivity.

Authors:  Kate S Collison; Nadine J Makhoul; Marya Z Zaidi; Soad M Saleh; Bernard Andres; Angela Inglis; Rana Al-Rabiah; Futwan A Al-Mohanna
Journal:  PLoS One       Date:  2012-04-03       Impact factor: 3.240

Review 9.  Neuropathological Mechanisms of Seizures in Autism Spectrum Disorder.

Authors:  Richard E Frye; Manuel F Casanova; S Hossein Fatemi; Timothy D Folsom; Teri J Reutiman; Gregory L Brown; Stephen M Edelson; John C Slattery; James B Adams
Journal:  Front Neurosci       Date:  2016-05-10       Impact factor: 4.677

10.  Effect of developmental NMDAR antagonism with CGP 39551 on aspartame-induced hypothalamic and adrenal gene expression.

Authors:  Kate S Collison; Angela Inglis; Sherin Shibin; Soad Saleh; Bernard Andres; Rosario Ubungen; Jennifer Thiam; Princess Mata; Futwan A Al-Mohanna
Journal:  PLoS One       Date:  2018-03-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.